Drug Trial Radar · NCT06449859
A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects
Last checked: Nov 19, 2026Latest source record: Jun 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
84
Planned (sponsor's estimate)
Start
Jun 13, 2023
Primary completion
Nov 2024
Study completion Nov 2024
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 10, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study is designed in two phases: single-dose administration and multiple-dose administration. A randomized, double-blind, placebo-controlled trial design was used to evaluate the safety, tolerability, pharmacokinetic characteristics and immunogenicity of TQC2938 injection in healthy adults.
Conditions
- Asthma
Interventions
TQC2938 InjectionDrug
TQC2938 injection is a humanized monoclonal antibody that interfering with the signal cascade.
TQC2938 PlaceboDrug
TQC2938 Placebo is a placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse events (AEs)Time frame: Single dose: Up to Day 113. Multiple doses: Up to Day 169
- Serious adverse events (SAEs)Time frame: Single dose: Up to Day 113. Multiple doses: Up to Day 169
- Clinical laboratory abnormalitiesTime frame: Single dose: Up to Day 113. Multiple doses: Up to Day 169
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.